Related Experiment Video

Updated: Aug 10, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 27, 2014

Development of a cancer-targeted tissue-specific promoter system

Takuya Fukazawa1, Yutaka Maeda, Frances M Sladek

  • 1Department of Biomedical Sciences, University of California, Riverside, California, USA. FukazawaT@aol.com

Cancer Research
|January 20, 2004
PubMed

Insights

This study introduces a novel dual promoter system for cancer gene therapy, enhancing specificity and reducing side effects. The TTS system effectively targets lung cancer cells while remaining controllable and adaptable for other cancer types.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Oncology

Background:

  • Cancer gene therapy faces challenges with specificity, leading to side effects.
  • Existing therapies lack precise targeting of cancer cells, affecting normal tissues.

Purpose of the Study:

  • To design a novel dual promoter system for cancer-targeted, tissue-specific gene therapy.
  • To develop a system that enhances therapeutic gene expression specifically in cancer cells.
  • To create a controllable and adaptable platform for various cancer types.

Main Methods:

  • Developed a dual promoter system combining cancer-specific and tissue-specific elements.
  • Engineered the TTS (TTF1 gene under the control of human telomerase reverse transcriptase promoter and human surfactant protein A1 promoter) system for lung cancer.
  • Incorporated drug-controllable elements using negative glucocorticoid responsive elements.

Main Results:

  • The TTS system demonstrated significantly higher promoter activity in lung cancer cells compared to other cancers and normal cells.
  • The system showed specificity, targeting lung cancer cells effectively.
  • The drug-controllable feature was successfully integrated into the promoter system.

Conclusions:

  • The novel dual promoter system offers improved specificity and control for cancer gene therapy.
  • The TTS system presents a promising approach for targeted lung cancer treatment.
  • The adaptable design allows for potential application in targeting other cancer types.

More Related Videos

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland06:29

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland

Published on: June 7, 2019

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...